Cargando…

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer

BACKGROUNDS: Fatty acid synthase (FASN) has been regarded as a prognostic marker in prostate cancer (PCa). In this study, we evaluated FASN expression at both mRNA and protein levels and assessed the association between FASN expression and prognosis in male Han Chinese with PCa treated with radical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Zhi, Xu, Yalong, Guo, Fei, Chen, Xi, Ji, Jin, Xu, Huan, He, Jingyi, Yu, Yongwei, Sun, Yinghao, Lu, Xin, Wang, Fubo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321525/ https://www.ncbi.nlm.nih.gov/pubmed/32655718 http://dx.doi.org/10.1155/2020/3904947

Ejemplares similares

The preoperative neutrophil‐to‐lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy
por: Cao, Zhi, et al.
Publicado: (2019)

Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
por: Li, Yun, et al.
Publicado: (2021)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer
por: Yang, Yi, et al.
Publicado: (2018)

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
por: Jiang, Donggen, et al.
Publicado: (2018)

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer
por: Qin, Guo-qiang, et al.
Publicado: (2014)

Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
por: Xu, Huan, et al.
Publicado: (2022)

Identification of Acetylation Sites of Fatty Acid Synthase (FASN) by Mass Spectrometry and FASN Activity Assay
por: Miao, Ting, et al.
Publicado: (2023)

FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
por: Chianese, Ugo, et al.
Publicado: (2023)

Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer
por: Ji, Jin, et al.
Publicado: (2021)

Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
por: Bastos, Débora C, et al.
Publicado: (2020)

KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer
por: Cao, Zhi, et al.
Publicado: (2021)

MAPK/P53-mediated FASN expression in bone tumors
por: Jiang, Ye, et al.
Publicado: (2017)

Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
por: Xu, Huan, et al.
Publicado: (2019)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2019)

The fasn-1(g14ts) allele is a Gly1830Arg missense mutation in C. elegans FASN-1
por: Bai, Xiaofei, et al.
Publicado: (2020)

Up‐regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence
por: Huang, Jin‐Bei, et al.
Publicado: (2020)

UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy
por: Wan, Xuechao, et al.
Publicado: (2016)

Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
por: Lyu, Ji, et al.
Publicado: (2019)

Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival
por: Zhao, Junjie, et al.
Publicado: (2016)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

FASN activity is important for the initial stages of the induction of senescence
por: Fafián-Labora, Juan, et al.
Publicado: (2019)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2015)

Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer
por: Chen, Yan-Fei, et al.
Publicado: (2019)

AB122. MicroRNA-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence
por: Xu, Chuanliang, et al.
Publicado: (2014)

Association Between Contrast-Enhanced Ultrasound Indicators and Prostate Cancer Biochemical Recurrence After Treatment
por: Mei, Jiang-jun, et al.
Publicado: (2020)

Impact of Glutathione-S-Transferases (GST) Polymorphisms and Hypermethylation of Relevant Genes on Risk of Prostate Cancer Biochemical Recurrence: A Meta-Analysis
por: Chen, Rui, et al.
Publicado: (2013)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016)

FASN-Mediated Lipid Metabolism Regulates Goose Granulosa Cells Apoptosis and Steroidogenesis
por: Chen, Xi, et al.
Publicado: (2020)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
por: Yang, Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2bgk606b3l9lorbvqn6o78dkic